SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (22735)6/26/1998 11:13:00 AM
From: celeryroot.com  Respond to of 32384
 
yes, but Lgnd doesn;t deal with the likes of DH Blair.Where as, Enmd does.



To: Phil Cressman who wrote (22735)6/26/1998 12:22:00 PM
From: Hippieslayer  Read Replies (1) | Respond to of 32384
 
The implications of ENTREMED's drug far outways lgnd's recent announcements. Not that lgnd's recent announcements are insifgnificant, but it's exactly correct in how the story is spun. LGND is like Judge Starr. Can;t spin if their life dependended on it. LGND will have to rely on "results" in humans to get the stock going.
Lgnd Breakout is turning into an oxymoron


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News